Want to see BLMH full AI Analyst Report?
Top Page
Blum Holdings
(OTC:BLMH)
Select Model
Select Model
Rating:41Neutral
Price Target:
$0.23
▼(-66.81% Downside)
Action:Reiterated
Date:07/01/26
The score is primarily weighed down by weak financial performance: recurring losses, negative operating/free cash flow, and negative equity create elevated fundamental risk despite some stabilization signals (2025 revenue rebound and reduced debt). Valuation provides limited support because earnings are negative and no dividend yield is available. Technicals cannot materially influence the rating due to missing indicator data.
Positive Factors
Debt Reduction
Material debt reduction meaningfully lowers leverage and interest burden, improving financial flexibility and runway. This reduces refinancing risk and gives management scope to prioritize operational fixes or strategic investments without immediate debt pressure, a durable structural improvement.
Negative Factors
Persistent Negative Cash Flow
Consistent negative operating and free cash flow erodes liquidity and forces reliance on external financing or asset sales. Over months, continued cash burn limits the firm's ability to reinvest, scale operations, or withstand downturns, making long-term self-funding and stability uncertain without structural change.
Read all positive and negative factors
Positive Factors
Negative Factors
Debt Reduction
Material debt reduction meaningfully lowers leverage and interest burden, improving financial flexibility and runway. This reduces refinancing risk and gives management scope to prioritize operational fixes or strategic investments without immediate debt pressure, a durable structural improvement.
Read all positive factors
Blum Holdings (BLMH) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$7.57M
Dividend YieldN/A
Average Volume (3M)2.87K
Price to Earnings (P/E)―
Beta (1Y)1.76
Revenue Growth-17.16%
EPS Growth-143.16%
CountryUS
Employees38
SectorHealthcare
Sector Strength45
IndustryDrug Manufacturers - Specialty & Generic
Share Statistics
EPS (TTM)-0.46
Shares Outstanding31,528,812
10 Day Avg. Volume2,994
30 Day Avg. Volume2,867
Financial Highlights & Ratios
PEG Ratio0.01
Price to Book (P/B)-1.14
Price to Sales (P/S)0.55
P/FCF Ratio-3.22
Enterprise Value/Market Cap1.28
Enterprise Value/Revenue0.65
Enterprise Value/Gross Profit1.43
Enterprise Value/Ebitda-1.72
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Blum Holdings Business Overview & Revenue Model
Company Description
Blum Holdings, Inc. is an entity operating within California's regulated cannabis market, comprehensively addressing both medical and adult-use demands. The company's multifaceted involvement encompasses the cultivation, production, distribution, ...
How the Company Makes Money
null...
Blum Holdings Financial Statement Overview
Summary
Income Statement
28
Negative
Balance Sheet
18
Very Negative
Cash Flow
22
Negative
| Breakdown | Dec 2025 | Dec 2024 | Mar 2024 | Dec 2022 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 14.91M | 12.99M | 33.23M | 52.02M | 42.12M |
| Gross Profit | 6.00M | 6.21M | 14.00M | 16.90M | 11.02M |
| EBITDA | -6.30M | 22.00M | -2.26M | -171.57M | -30.07M |
| Net Income | -7.96M | 33.10M | -14.13M | -188.93M | -31.27M |
Balance Sheet | |||||
| Total Assets | 44.52M | 24.82M | 32.07M | 40.51M | 271.82M |
| Cash, Cash Equivalents and Short-Term Investments | 813.00K | 1.04M | 862.00K | 1.20M | 6.70M |
| Total Debt | 7.50M | 4.79M | 37.70M | 49.56M | 79.41M |
| Total Liabilities | 48.74M | 29.56M | 77.77M | 77.05M | 125.34M |
| Stockholders Equity | -7.17M | -6.75M | -45.70M | -36.54M | 142.63M |
Cash Flow | |||||
| Free Cash Flow | -2.53M | -2.15M | -1.29M | -9.76M | -21.93M |
| Operating Cash Flow | -2.50M | -2.14M | -965.00K | -7.83M | -17.96M |
| Investing Cash Flow | -971.00K | 2.03M | 462.00K | 19.61M | 21.67M |
| Financing Cash Flow | 3.25M | 143.00K | 539.00K | -17.27M | 4.50M |
Blum Holdings Technical Analysis
Positive
0.69
Price Trends
0.24
Negative
0.25
Negative
0.43
Negative
Market Momentum
-0.01
Negative
52.85
Neutral
33.33
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For BLMH, the sentiment is Positive. The current price of 0.69 is above the 20-day moving average (MA) of 0.23, above the 50-day MA of 0.24, and above the 200-day MA of 0.43, indicating a neutral trend. The MACD of -0.01 indicates Negative momentum. The RSI at 52.85 is Neutral, neither overbought nor oversold. The STOCH value of 33.33 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for BLMH.
Blum Holdings Risk Analysis
Blum Holdings disclosed 56 risk factors in its most recent earnings report. Blum Holdings reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Blum Holdings Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
52 Neutral | $53.46M | -2.87 | -92.98% | ― | -96.30% | 32.21% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
47 Neutral | $7.07M | -1.66 | -40.66% | ― | 2.00% | 94.31% | |
45 Neutral | $12.11M | -0.85 | -476.72% | ― | 13.70% | 33.33% | |
42 Neutral | $1.05M | -11.21 | -93.87% | ― | -6.14% | -24.22% | |
41 Neutral | $7.57M | -0.52 | -140.00% | ― | -17.16% | -143.16% |
* Healthcare Sector Average
BLMH
Blum Holdings
0.24
-0.40
-62.50%
TLPH
Talphera
1.03
0.58
128.38%
SISI
Shineco
0.30
-9.80
-96.99%
YCBD
cbdMD
0.67
-0.19
-21.74%
IMCC
IM Cannabis Corp
0.17
-2.53
-93.78%
BFRI
Biofrontera
0.95
0.26
37.35%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.